Lakefront Biotherapeutics NV (GLPG) Form 6-K — Oct 13, 2026
Lakefront Biotherapeutics NV repurchased 126,322 of its own shares between October 5 and October 9, 2026, spending €3,317,407.94 at an average price of €26.26 as part of the buyback program announced June 9, 2026. Purchases were executed via a discretionary mandate to an independent financial intermediary across Euronext Brussels and other venues, with per-share prices ranging from €25.78 to €26.78. As of market close on October 9, 2026, the company holds 1,877,353 of its own ordinary shares in treasury.
Key figures
- Lowest Price Eur
- 25.78
- Average Price Eur
- 26.26
- Highest Price Eur
- 26.78
- Shares Held As Treasury
- 1877353
- Shares Repurchased Week
- 126322
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.